Clinical Trials Logo

Hyperoxia clinical trials

View clinical trials related to Hyperoxia.

Filter by:

NCT ID: NCT05395975 Completed - Hypoxia Clinical Trials

Different Preoxygenation Methods In Cesarean Section

Start date: December 1, 2020
Phase:
Study type: Observational

The study aimed to evaluate different preoxygenation methods (tidal volume for 3 minutes and 4 deep breaths) in pregnant women with oxygen reserve index (ORI). After the routine monitoring of healthy ASA II pregnant patients between the ages of 18-45, different preoxygenation methods will be applied, and the oxygen status of the patients will be compared with ORI monitoring.

NCT ID: NCT05354648 Completed - Clinical trials for Coronary Artery Disease

Effects of Hypoxic-hyperoxic Preconditioning in Cardio-surgical Patients

Start date: June 1, 2015
Phase: N/A
Study type: Interventional

Coronary artery bypass grafting (CABG) with cardiopulmonary bypass is a common surgical therapy for patients suffering from coronary artery diseases. The heart is subjected to a long period of ischemia due to the occlusion of the aorta. The heavy burden of myocardial ischemia-reperfusion injury (IRI) thus induces cardiomyocyte death, which can paradoxically reduce the beneficial effect of CABG. Preconditioning by moderate hypoxia or hyperoxia serves as an effective drug-free method to increase the organism's resistance to negative effects, including IRI.

NCT ID: NCT05235386 Not yet recruiting - COVID-19 Clinical Trials

Clinical Impact of Automated Oxygen Administration on Confirmed or Suspected COVID-19 in the Emergency Department.

Start date: February 2022
Phase:
Study type: Observational

The aim of this study is to evaluate the impact of the FreeO2 system on the quality of the oxygen therapy in confirmed or suspected SARS-CoV-2 patients in the emergency department.

NCT ID: NCT05150418 Completed - Hypovolemia Clinical Trials

Supplemental Oxygen in Hypovolemia

Start date: November 26, 2021
Phase: Phase 1
Study type: Interventional

Supplemental oxygen is frequently administered in acutely and critically ill patients, specifically, it is often administered in trauma patients to avoid arterial hypoxemia and tissue hypoxia. There is also an increasing focus on potentially deleterious effects of hyperoxia. Further, the hemodynamic response to hyperoxia in hypovolemia is poorly understood. The present study aims to investigate the effects of supplemental oxygen on systemic and cerebral hemodynamics in simulated hypovolemia in healthy volunteers.

NCT ID: NCT05128422 Recruiting - Stroke Clinical Trials

Normobaric Hyperoxia Combined With Endovascular Treatment for Acute Ischemic Stroke

Start date: October 27, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the safety and efficiency of normobaric hyperoxia combined with endovascular treatment for acute ischemic stroke patients with stroke onset 6-24 hours.

NCT ID: NCT05099523 Completed - Stress Clinical Trials

Intraoperative Different Concentrations Oxygen And Oxidatıve Stress Markers

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

The aim of the study was to assess the effect of intraoperative oxygen (O2), which was applied at 30% and 50% concentrations on patients who had undergone septoplasty surgery, on Total Oxidant Status (TOS), Total Antioxidant Status (TAS), and Oxidative Stress Index (OSI).

NCT ID: NCT05039697 Recruiting - Stroke, Acute Clinical Trials

Normobaric Hyperoxia Combined With Endovascular Therapy in Patients With Stroke Within 6 Hours of Onset:Longterm Outcome

NBOL
Start date: April 1, 2021
Phase: N/A
Study type: Interventional

The overall incidence of good outcome for AIS following endovascular treatment is only proximately 50%. Whether NBO was safe and effective to improve acute ischemic stroke prognosis is still unclear. The investigators' hypothesis is thatNBO is a safe and effective strategy to improve longterm outcome in AIS patients undergoing endovascular treatment.

NCT ID: NCT04978636 Recruiting - Cardiac Surgery Clinical Trials

Low Tidal Volume Ventilation With Hyperoxia Avoidance During Cardiopulmonary Bypass (The FOCUS Trial)

Start date: September 20, 2021
Phase: N/A
Study type: Interventional

This is a multi-institutional study (CCF, UPMC, OSU) evaluating different ventilation strategies during cardiopulmonary bypass on mortality and postoperative pulmonary complications, with sub-study investigating 8-iso-prostaglandin F2a and sRAGE levels.

NCT ID: NCT04955561 Recruiting - COPD Clinical Trials

CO2-Patterns During Hyperoxia and Physical Exercise in COPD

Start date: July 13, 2021
Phase: N/A
Study type: Interventional

The aim of the study is to investigate a possible correlation between the change in PCO2 during a hyperoxia-test and the change in PCO2 during walking in people with COPD

NCT ID: NCT04879290 Completed - Anesthesia Clinical Trials

Comparison of Two FiO2 (1 or 0.5) for Tracheal Extubation in Post-anesthesia Care Unit

EXTUBO2
Start date: April 9, 2021
Phase: N/A
Study type: Interventional

The purpose of the study is to assess the optimal fraction of inspired oxygen (0.5 or 1) for extubation or removal of a supraglottic airway device after general anesthesia.